Clinical Trial Update: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract [Phase 2]

View source ↗

Summary

This update describes an ongoing Phase 2 multicenter, randomized, double-masked, placebo-controlled pilot study assessing the efficacy and safety of ZOC2017217 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Cataract

Drugs mentioned

• ZOC2017217

Snippet

Sponsor: Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. | Conditions: Age Related Cataracts | Phase 2 | Status: ENROLLING_BY_INVITATION